Chronic Myeloid Leukemia

269 clinical trials · Condition

Record	Firm	Date
Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia (NCT00513175)	University of California, San Francisco	2001-10-01
Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate (NCT00038675)	M.D. Anderson Cancer Center	2001-06-01
Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients (NCT00219765)	Poitiers University Hospital	2001-05-01
Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON) (NCT00511121)	University of Bologna	2001-04-01
Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia in Accelerated and Blastic Phase (NCT00514969)	University of Bologna	2000-08-01
Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia (NCT00001144)	National Heart, Lung, and Blood Institute (NHLBI)	1999-10-01
The Randomized Study of Dasatinib and High-Dose Imatinib (600mg) in Suboptimal Responder (NCT00854841)	Pusan National University Hospital
Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation (NCT02258490)	Emory University
Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant (NCT01200017)	Christopher Dvorak

Track Chronic Myeloid Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.